The promises and pitfalls of omics in precision medicine.
Omics techniques that rapidly analyze large amounts of genomic and other data from an individual cell, tissue or patient could greatly benefit precision medicine, but not without challenges. The Regulatory Science to Advance Precision Medicine Working Group, led by scientists at the University of Rochester Clinical and Translational Science Institute, held a forum in 2017 to examine those possibilities and challenges. Members of the NIH, FDA, CTSA Program, foundations and industry explored how to apply omics techniques to precision medicine and revolutionize patient diagnosis and therapeutic interventions. Their findings were recently published in the Journal of Clinical and Translational Science.